TY - JOUR
T1 - Jietacins, azoxy antibiotics with potent nematocidal activity
T2 - Design, synthesis, and biological evaluation against parasitic nematodes
AU - Sugawara, Akihiro
AU - Kubo, Masahiko
AU - Hirose, Tomoyasu
AU - Yahagi, Kyoichi
AU - Tsunoda, Noriaki
AU - Noguchi, Yoshihiko
AU - Nakashima, Takuji
AU - Takahashi, Yoko
AU - Welz, Claudia
AU - Mueller, Dennis
AU - Mertens, Christina
AU - Koebberling, Johannes
AU - Ōmura, Satoshi
AU - Sunazuka, Toshiaki
N1 - Funding Information:
We thank funds from the Quality Assurance Framework of Higher Education from the Ministry of Education, Culture, Sports, Science and Technology (MEXT) , Japan, and the Kitasato University Research Grant for Young Researchers (to A.S.) for support of this work. We also thank Dr Kenichiro Nagai, Ms Noriko Sato (Kitasato University) for various instrumental analyses, as well as Dr Hidehito Matsui and Prof Hideaki Hanaki (Kitasato University) for measurement of antibacterial activity.
Publisher Copyright:
© 2017
PY - 2018/2/10
Y1 - 2018/2/10
N2 - Jietacins, an azoxy antibiotic class of chemicals, were isolated from the culture broth of Streptomyces sp. KP-197. They have a unique structural motif, including a vinyl azoxy group and a long acyclic aliphatic chain, which is usually branched but non-branched in the case of jietacin C. During a drug discovery program, we found that jietacins display potent anthelmintic activity against parasitic nematodes and that jietacin A has a moderate or low acute toxicity (LD50 > 300 mg/kg) and no mutagenic potential in a mini Ames screen. This suggests that jietacins have potential for drug discovery research. In order to create a novel anthelmintic agent, we performed design, synthesis, and biological evaluation of jietacin derivatives against parasitic nematodes. Of these derivatives, we found that a fully synthesized simplified derivative exhibited better anthelmintic activity against three parasitic nematodes than natural jietacins. In addition, it had a better efficacy in vivo through oral administration against a mouse nematode. This indicated that the azoxy motif could prove useful as a template for anthelmintic discovery, possibly creating a class of anthelmintic with novel skeletons, a potential new mode of action, and providing further insight for rational drug design.
AB - Jietacins, an azoxy antibiotic class of chemicals, were isolated from the culture broth of Streptomyces sp. KP-197. They have a unique structural motif, including a vinyl azoxy group and a long acyclic aliphatic chain, which is usually branched but non-branched in the case of jietacin C. During a drug discovery program, we found that jietacins display potent anthelmintic activity against parasitic nematodes and that jietacin A has a moderate or low acute toxicity (LD50 > 300 mg/kg) and no mutagenic potential in a mini Ames screen. This suggests that jietacins have potential for drug discovery research. In order to create a novel anthelmintic agent, we performed design, synthesis, and biological evaluation of jietacin derivatives against parasitic nematodes. Of these derivatives, we found that a fully synthesized simplified derivative exhibited better anthelmintic activity against three parasitic nematodes than natural jietacins. In addition, it had a better efficacy in vivo through oral administration against a mouse nematode. This indicated that the azoxy motif could prove useful as a template for anthelmintic discovery, possibly creating a class of anthelmintic with novel skeletons, a potential new mode of action, and providing further insight for rational drug design.
KW - Anthelmintic
KW - Jietacin
KW - Late-stage diversification
KW - Natural product
KW - Nematocidal
KW - Vinyl azoxy
UR - http://www.scopus.com/inward/record.url?scp=85040366852&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85040366852&partnerID=8YFLogxK
U2 - 10.1016/j.ejmech.2017.12.031
DO - 10.1016/j.ejmech.2017.12.031
M3 - Article
C2 - 29335213
AN - SCOPUS:85040366852
SN - 0223-5234
VL - 145
SP - 524
EP - 538
JO - CHIM.THER.
JF - CHIM.THER.
ER -